Literature DB >> 1168607

The effect of cholestyramine on intestinal absorption.

R J West, J K Lloyd.   

Abstract

Cholestyramine in a mean dosage of 0-6 g/kg/day has been given to 18 children with familial hypercholesterolaemia for between one and two and a half years. With prolonged treatment folate deficiency occurred, as evidenced by a fall in the mean serum folate concentration from 7-7 ng/ml before treatment to 4-4 ng/ml for patients on treatment for over one year; a corresponding lowering of red cell folate was also seen. Oral folic acid 5 mg daily overcame this depletion, and should be given to all patients on long-term anion exchange resins. Prothrombin time has remained normal in all patients; there has been a significant decrease in the mean serum concentrations of vitamins A and E and of inorganic phosphorus over the first two years of treatment, although values remain within the normal range. The routine administration of fat-soluble vitamins appears unnecessary but it is prudent to measure prothrombin time and serum vitamins A and E at intervals. In children who were having a normal intake of dietary fat five out of seven tested had faecal fat of over 5 g/day while on cholestyramine. No chold has developed diarrhoea, and growth has been normal. The concentrations of serum iron, vitamin B12, plasma calcium, and protein did not change significantly in any patient.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1168607      PMCID: PMC1410988          DOI: 10.1136/gut.16.2.93

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  UTILIZATION OF FAT-SOLUBLE VITAMINS BY RATS AND CHICKS FED CHOLESTYRAMINE, A BILE ACID SEQUESTRANT.

Authors:  C H Whiteside; R W Harkins; H B Fluckiger; H P Sarett
Journal:  Am J Clin Nutr       Date:  1965-03       Impact factor: 7.045

2.  Treatment of pruritus of obstructive jaundice with cholestyramine.

Authors:  D V DATTA; S SHERLOCK
Journal:  Br Med J       Date:  1963-01-26

3.  Xanthomatous biliary cirrhosis treated with cholestyramine. A bile-acid-adsorbing resin.

Authors:  R E VISINTINE; G D MICHAELS; G FUKAYAMA; J CONKLIN; L W KINSELL
Journal:  Lancet       Date:  1961-08-12       Impact factor: 79.321

4.  Experimental steatorrhea induced in man by bile acid sequestrant.

Authors:  S A HASHIM; S S BERGEN; T B VAN ITALLIE
Journal:  Proc Soc Exp Biol Med       Date:  1961-01

5.  Effect of an anion exchange resin on serum cholesterol in man.

Authors:  S S BERGEN; T B VAN ITALLIE; D M TENNENT; W H SEBRELL
Journal:  Proc Soc Exp Biol Med       Date:  1959 Oct-Dec

6.  Effect of cholestyramine on the absorption of vitamin D3 and calcium.

Authors:  W G Thompson; G R Thompson
Journal:  Gut       Date:  1969-09       Impact factor: 23.059

7.  Serum parathyroid hormone and blood minerals: interrelationships in normal children.

Authors:  S B Arnaud; R S Goldsmith; G B Stickler; J T McCall; C D Arnaud
Journal:  Pediatr Res       Date:  1973-05       Impact factor: 3.756

8.  Acquired hyperoxaluria, nephrolithiasis, and intestinal disease. Description of a syndrome.

Authors:  L H Smith; H Fromm; A F Hofmann
Journal:  N Engl J Med       Date:  1972-06-29       Impact factor: 91.245

9.  Osteomalacia associated with cholestyramine therapy for postileectomy diarrhea.

Authors:  K W Heaton; J V Lever; D Barnard
Journal:  Gastroenterology       Date:  1972-04       Impact factor: 22.682

10.  Cholestyramine treatment of diarrhea associated with ileal resection.

Authors:  A F Hofmann; J R Poley
Journal:  N Engl J Med       Date:  1969-08-21       Impact factor: 91.245

View more
  18 in total

Review 1.  A comparative review of the adverse effects of treatments for hyperlipidaemia.

Authors:  A Steiner; B Weisser; W Vetter
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

2.  Hyperlipidaemia, smoking and hypertension. The place of the hyperlipidaemias.

Authors:  J K Lloyd; R J West
Journal:  Postgrad Med J       Date:  1978-03       Impact factor: 2.401

Review 3.  A rational approach to treating hypercholesterolaemia in children. Weighing the risks and benefits.

Authors:  S Tonstad
Journal:  Drug Saf       Date:  1997-05       Impact factor: 5.606

Review 4.  Drugs and vitamin deficiency.

Authors:  L Ovesen
Journal:  Drugs       Date:  1979-10       Impact factor: 9.546

Review 5.  Pruritus associated with cholestasis. A review of pathogenesis and management.

Authors:  M Khandelwal; P F Malet
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

6.  [Drugs and vitamins].

Authors:  G Czok
Journal:  Z Ernahrungswiss       Date:  1978-09

7.  Double-blind trial of cholestyramine in post-vagotomy diarrhoea.

Authors:  V M Duncombe; T D Bolin; A E Davis
Journal:  Gut       Date:  1977-07       Impact factor: 23.059

8.  Ascorbic acid deficiency in liver disease.

Authors:  A D Beattie; S Sherlock
Journal:  Gut       Date:  1976-08       Impact factor: 23.059

Review 9.  Calcium-sensing receptor: A new target for therapy of diarrhea.

Authors:  Sam Xianjun Cheng
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

Review 10.  Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment.

Authors:  Alan N Barkun; Jonathan Love; Michael Gould; Henryk Pluta; Hillary Steinhart
Journal:  Can J Gastroenterol       Date:  2013-11       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.